# Commission Regulation (EC) No 761/2009 of 23 July 2009 amending, for the purpose of its adaptation to technical progress, Regulation (EC) No 440/2008 laying down test methods pursuant to Regulation (EC) No 1907/2006 of the European Parliament and of the Council on the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH) (Text with EEA relevance), Division 1.6.1.5: Assay Acceptability Criteria

Extent: E+W+S+N.I.

For each assay using valid batches (see paragraph 1.6.1.2.5), tissues treated with the NC should exhibit OD reflecting the quality of the tissues that followed all shipment and receipt steps and all the irritation protocol process. The OD values of controls should not be below historical established lower boundaries. Similarly, tissues treated with the PC, i.e. 5 % aqueous SDS, should reflect the sensitivity retained by tissues and their ability to respond to an irritant substance in the conditions of each individual assay (e.g. viability ≤ 40 % for the validated reference method 1, and ≤ 20 % for the validated reference method 2). Associated and appropriate measures of variability between tissue replicates should be defined (e.g. if standard deviations are used they should be ≤ 18 %).

---
Source: https://www.legislation.gov.uk/eur/2009/761/annex/III/division/1/division/1.6/division/1.6.1/division/1.6.1.5 (the official version)
Page: https://openlegislation.uk/eu-regulation-2009-761/annex-III/division-1/division-1.6/division-1.6.1/division-1.6.1.5
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.

